Deyu Li

机构：Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou People's Hospital · ORCID：0000-0002-6615-8316

发表论文 76 篇 · 总被引 885 次 · h-index 13

代表论文

• Multi-omics integration and machine learning uncover molecular basal-like subtype of pancreatic cancer and implicate A2ML1 in promoting tumor epithelial-mesenchymal transition (2025 · Journal of Translational Medicine · 被引 13)
• Impact of antifibrotic therapy on disease progression, all-cause mortality, and risk of acute exacerbation in non-IPF fibrosing interstitial lung diseases: evidence from a meta-analysis of randomized controlled trials and prospective controlled studies (2024 · Therapeutic Advances in Respiratory Disease · 被引 13)
• GBP5 Expression Predicted Prognosis of Immune Checkpoint Inhibitors in Small Cell Lung Cancer and Correlated with Tumor Immune Microenvironment (2023 · Journal of Inflammation Research · 被引 13)
• New HCC Subtypes Based on CD8 Tex-Related lncRNA Signature Could Predict Prognosis, Immunological and Drug Sensitivity Characteristics of Hepatocellular Carcinoma (2024 · Journal of Hepatocellular Carcinoma · 被引 10)
• Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study (2024 · Scientific Reports · 被引 8)
• Chinese multicenter expert consensus on the diagnosis and treatment of hilar cholangiocarcinoma: 2025 edition (2025 · BioScience Trends · 被引 5)